Asia-Pacific's growing ageing population has led to increased innovation in the bone and joint health supplement space, but products targeting more life stages and categories are also finding success in the sector.
UK firm OptiBiotix is looking to increase its APAC presence, with Food Standards and Safety Authority of India (FSSAI) approval the latest development in its expansion plans withits weight management product, SlimBiome.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.
Find out what Australian, Japanese and Kiwi researchers have discovered about probiotics and the gut microbiome, how diet can affect Alzheimer's risk, and whether naturopathy is effective against chronic disease in our latest science round-up.
Read about diet's influence on cancer and Alzheimer's risk, China's '100-day operation', and new innovations and research in the gut health space in this round-up of our top five trending stories on social media.
The world's first systemic scoping study, conducted by researchers at Australia's Southern Cross University, has reported the clinical benefits of naturopathic medicine for a variety of chronic conditions.
Amway India is striving to promote the health benefits of traditional Indian herbs to consumers in the market, having recently conducted a series of seminars showcasing its Nutrilite Traditional Herbs range of supplements.